Content about Collaborative Care

February 17, 2012
Pfizer cancer drug hits BioPlus' shelves

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

February 16, 2012
CMPI survey: 61 million workers avoided missing work, thanks to cough medicine

Results of a new survey released Thursday by the Center for Medicine in the Public Interest found that the majority of adult consumers and parents in the United States rely on over-the-counter cough medicines.

February 16, 2012
Giant-Carlisle installs solar panels at two stores

One of the supermarket chains operated by Netherlands-based Royal Ahold has installed rooftop solar panels at two of its stores.

February 16, 2012
Insulet, LifeScan ink deal

Insulet and LifeScan have entered a partnership through which the latter's OneTouch blood-glucose monitoring technology will be integrated into the former's OmniPod Personal Diabetes Manager.

February 16, 2012
More diagnoses to drive celiac disease market growth through decade

The global market for celiac disease is expected to grow substantially over the decade as more people are diagnosed with the condition, according to a new report.

February 16, 2012
National Diabetes Prevention Program gets $10 million in funding from HHS

The Department of Health and Human Services is providing $10 million in fiscal year 2012 funding for the Centers for Disease Control and Prevention's National Diabetes Prevention Program.

February 16, 2012
Nearly 23 million Americans suffering from untreated hearing loss

Though an estimated 26.7 million Americans ages 50 years and older have hearing loss, only about 1-in-7 of them uses a hearing aid, according to a new study led by Johns Hopkins researchers that was released Monday.

February 16, 2012
Partnership aims to address adherence among hard-to-reach populations

Poor medication adherence is a national problem, but it can be particularly problematic among populations with low health literacy or limited English proficiency.

February 16, 2012
Study identifies Type 2 diabetes genetic variants linked to ethnicity

A new study has found several gene variants associated with Type 2 diabetes across different ethnic groups.

February 16, 2012
Study: Blood from periodontal disease can be used to screen for diabetes

Oral blood samples drawn from periodontal inflammation can be used to measure HbA1C levels, a factor that indicates a patient's diabetes status, according to a New York University study.

February 16, 2012
Up to 45,000 Nebraska state employees to regain access to Walgreens with health plan switch

Nebraska officials on Wednesday announced the state will switch health insurance carriers from Blue Cross/Blue Shield to United Healthcare, effective July 1, according to reports.

February 16, 2012
Walgreens partners on adherence pilot with Greystone Healthcare Management

Walgreens and Greystone Healthcare Management on Thursday launched a collaborative therapy management pilot program at the Lady Lake Specialty Center in Lady Lake, Fla., aimed at enhancing medication adherence and reducing readmission rates for patients in post-acute care settings.

February 15, 2012
Biogen Idec to acquire Stromedix

Drug maker Biogen Idec plans to spend up to more than $560 million to buy a company developing treatments for organ failure.

February 15, 2012
Botanical Labs showcases gluten-free across its Wellesse brands at Celiac Disease Foundation expo

Botanical Labs on Tuesday introduced its gluten-free line of liquid dietary supplements across its Wellesse line of liquid supplements — calcium/magnesium, vitamin D3, iron and B-complex — at the Celiac Disease Foundation's South Florida Chapter Gluten-Free Expo in West Palm Beach, Fla.

February 15, 2012
Counterfeit Avastin circulating in U.S., FDA warns

Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.

February 15, 2012
FDA accepts Pfizer application for genetic disease drug

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

February 15, 2012
Managed care plans prefer generic over branded Lipitor

Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

February 15, 2012
Medco launches specialty benefit management program

Pharmacy benefit manager Medco Health Solutions has launched a medical benefit management program that it said would help control spending on specialty drugs, the company said.

February 15, 2012
Mylan rebrands Dey Pharma unit

Mylan is changing the name of its branded specialty pharmaceutical business, the company said Wednesday.

February 15, 2012
NACDS, NCPA urge Congress to reject proposal that discourages Tricare patients' use of community pharmacies

The National Association of Chain Drug Stores and the National Community Pharmacists Association are urging Congress to reject budget proposals that would limit pharmacy choice for Tricare beneficiaries.

February 15, 2012
OptumRx earns URAC specialty pharmacy accreditation

A pharmacy benefit management organization has received accreditation for its specialty pharmacy program.

February 15, 2012
Sen. Mark Pryor, columnist Mort Kondracke to address NACDS RxImpact Day attendees

The National Association of Chain Drug Stores has announced that it will hold its fourth annual NACDS RxImpact Day on Capitol Hill on March 21 to 22 in Washington, D.C.

February 15, 2012
Thinq relaunches RTD line in small aluminum cans

Thinq on Wednesday announced the relaunch of its line of Thinq ready-to-drink beverages, now available in a 12-oz. Rexam Sleek can as its primary package.

February 14, 2012
Bristol-Myers Squibb completes Inhibitex acquisition

Bristol-Myers Squibb has completed its acquisition of a developer of hepatitis C treatments.

February 14, 2012
FDA grants priority review to Gilead's Truvada for HIV prevention

The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

© 2013 Drug Store News. All Rights Reserved.